IL319769A - Solid forms of mesodoptam and its salts - Google Patents
Solid forms of mesodoptam and its saltsInfo
- Publication number
- IL319769A IL319769A IL319769A IL31976925A IL319769A IL 319769 A IL319769 A IL 319769A IL 319769 A IL319769 A IL 319769A IL 31976925 A IL31976925 A IL 31976925A IL 319769 A IL319769 A IL 319769A
- Authority
- IL
- Israel
- Prior art keywords
- mesdopetam
- salts
- state forms
- therofsolid
- therof
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/16—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C317/22—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263408516P | 2022-09-21 | 2022-09-21 | |
| US202263422056P | 2022-11-03 | 2022-11-03 | |
| US202263422047P | 2022-11-03 | 2022-11-03 | |
| PCT/IB2023/059085 WO2024062344A1 (en) | 2022-09-21 | 2023-09-13 | Solid state forms of mesdopetam and salts therof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL319769A true IL319769A (en) | 2025-05-01 |
Family
ID=88146855
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL319769A IL319769A (en) | 2022-09-21 | 2023-09-13 | Solid forms of mesodoptam and its salts |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP4590657A1 (de) |
| CA (1) | CA3268423A1 (de) |
| IL (1) | IL319769A (de) |
| WO (1) | WO2024062344A1 (de) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2699543B1 (de) | 2011-04-19 | 2016-03-02 | Integrative Research Laboratories Sweden AB | Neue modulatoren der kortikalen dopaminergischen und nmda-rezeptorvermittelten glutamatergischen neurotransmission |
| BR112021023563A2 (pt) | 2019-05-24 | 2022-01-04 | Integrative Res Laboratories Sweden Ab | Sais farmaceuticamente aceitáveis de [2-(3-fluoro-5-metano-sulfonilfenóxi)etil](propil) amina e usos dos mesmos |
| JP2023519882A (ja) * | 2020-03-27 | 2023-05-15 | ソム、イノベーション、バイオテック、ソシエダッド、アノニマ | シヌクレイノパチーの治療に有用な化合物 |
| TW202233169A (zh) * | 2020-11-10 | 2022-09-01 | 瑞典商瑞典綜合研究實驗室公司 | 包含［２－（３－氟－５－甲磺醯苯氧基）乙基］（丙基）胺之醫藥上可接受鹽類的醫藥組成物、及治療帕金森氏症的藥物及所述醫藥組成物的用途 |
-
2023
- 2023-09-13 EP EP23776108.5A patent/EP4590657A1/de active Pending
- 2023-09-13 CA CA3268423A patent/CA3268423A1/en active Pending
- 2023-09-13 IL IL319769A patent/IL319769A/en unknown
- 2023-09-13 WO PCT/IB2023/059085 patent/WO2024062344A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP4590657A1 (de) | 2025-07-30 |
| WO2024062344A1 (en) | 2024-03-28 |
| CA3268423A1 (en) | 2024-03-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUE069889T2 (hu) | Belumoszudil és belumoszudil-sók szilárd formái | |
| IL288062A (en) | Crystalline forms of tapamidis and its salts | |
| IL290106B1 (en) | Crystalline form of ATR inhibitor and its use | |
| SG11202107614PA (en) | Pcsk9 inhibitors and methods of use thereof | |
| IL283480A (en) | Solid forms of lometaferon and lometaferon salts and processes for preparing lometaferon | |
| IL304680A (en) | Urolithin history and methods of using them | |
| IL312348A (en) | HIF-2ALPHA inhibitors and methods of using it | |
| IL310812A (en) | SOLID FORMS OF SPIROTRICYCLIC APOL1 INHIBITORS AND METHODS OF USING THEM | |
| GB2594788B (en) | Antagonist of PCSK9 | |
| IL321357A (en) | KIF18A inhibitors and their uses | |
| IL314320A (en) | Compounds and methods of use | |
| IL318393A (en) | Azaquinazoline compounds and methods of use | |
| IL319769A (en) | Solid forms of mesodoptam and its salts | |
| IL312041A (en) | R-ketamine salts and methods of using them | |
| IL314594A (en) | Heterocyclic compounds and methods of use | |
| IL314277A (en) | Anti-B7-H3 compounds and methods of use | |
| GB202401487D0 (en) | Salts and polymorphs of mitragynine and 3-deuteromitragynine | |
| IL321700A (en) | Salts and solid forms of sonrotoclax intermediate | |
| GB202119051D0 (en) | Wingsail and method of use | |
| CA3279207A1 (en) | Solid state forms of brilaroxazine and brilaroxazine salts | |
| EP4161488A4 (de) | Rho-kinasehemmer freisetzende implantate und zugehörige verfahren zur verwendung | |
| HK40128909A (zh) | Sonrotoclax中间体的盐及固体形式 | |
| CA3277370A1 (en) | Salts and solid forms of sonrotoclax intermediate | |
| IL326153A (en) | Solid state forms of GUSACITINIB | |
| IL326152A (en) | Solid state forms of GUSACITINIB |